Update date
31 Dec 2023
Shareable Research Card
EVOME MEDICAL TECHNOLOGIES INC. Share-based Payment Arrangement, Noncash Expense
This metric view shows EVOME MEDICAL TECHNOLOGIES INC. share-based payment arrangement, noncash expense history from SEC company facts.
Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.
- Context
- Latest reported period: 2023
- Latest reported value
- CA$1,288,455
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.
Return Loop
Why revisit this metric view
This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.
- Latest source-backed update
- Latest period end 31 Dec 2023
- Why come back
- Return after the next filing to verify whether this metric changed and how it compares with the ranking page.
- Current latest reported period: 2023.
- Latest reported value on this page: CA$1,288,455.
- Save this filer if you want to compare the next reported value with this history.
Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.
Latest update
Latest update for Share-based Payment Arrangement, Noncash Expense
Latest reported share-based payment arrangement, noncash expense: CA$1,288,455. Open the source-backed page to compare this metric with the newest filing-backed context.
Page type
Metric history
Latest period
2023
SEC-backed company facts were refreshed from filings filed on 16 Apr 2024.
Benchmark Context
How Share-based Payment Arrangement, Noncash Expense compares with peers
EVOME MEDICAL TECHNOLOGIES INC. sits in the upper half of the current share-based payment arrangement, noncash expense sample.
Compared with
Compared with 11 companies reporting share-based payment arrangement, noncash expense in CAD. This keeps the comparison on the same metric and unit family.
Why this is notable
This is about 1.4x the current sample midpoint. Share-based Payment Arrangement, Noncash Expense does not yet have enough prior-period data for a historical comparison on this page.
- Visible rows currently span reported period ends from 31 Jul 2017 to 31 May 2026.
- Nearby companies in this sample: Canopy Growth Corp and NexMetals Mining Corp..
- Current sample position: rank #5 of 11 comparable companies.
- Peer rows use the latest valid value per company for this exact metric and compatible units.
Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.
Save this filer page
Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.
Financial Metric Page
EVOME MEDICAL TECHNOLOGIES INC.: Share-based Payment Arrangement, Noncash Expense
Latest period: 2023. Period end: 31 Dec 2023. Units: CAD. Frequency: annual and quarterly.
Amount of noncash expense for share-based payment arrangement.
Metric snapshot
- Latest value
- CA$1,288,455
- Coverage range
- 28 Feb 2021 - 31 Dec 2023
- Fact rows
- 7
What this metric tells you
- Shows reported share-based payment arrangement, noncash expense over 28 Feb 2021 - 31 Dec 2023.
- Use consecutive periods in the table to assess trend direction when YoY change is unavailable.
- Built from 7 SEC fact rows for this metric and issuer.
How to read this chart
- Start with the latest point, then compare it with the prior periods to see direction.
- Use annual sequence to compare like-for-like periods.
- Use YoY change bars to separate growth from contraction across matching periods.
Official SEC source
Source: SEC company facts
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Reporting periods may differ by company.
Compare This Metric Across Companies
Compare latest available Share-based Payment Arrangement, Noncash Expense levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.
EVOME MEDICAL TECHNOLOGIES INC. appears at rank #5 in the latest comparison sample.
| Rank | Company | Latest value | Report period | Next step |
|---|---|---|---|---|
| 1 | ALGONQUIN POWER & UTILITIES CORP. (aqn) | CA$10,630,000 | Year - 31 Dec 2017 | Open ALGONQUIN POWER & UTILITIES CORP. Share-based Payment Arrangement, Noncash Expense |
| 2 | New Horizon Aircraft Ltd. (hovr) | CA$7,159,000 | Year - 31 May 2026 | Open New Horizon Aircraft Ltd. Share-based Payment Arrangement, Noncash Expense |
| 3 | SRX Global Inc. (srxh) | CA$5,062,000 | Year - 30 Sep 2024 | Open SRX Global Inc. Share-based Payment Arrangement, Noncash Expense |
| 4 | Canopy Growth Corp (cgc) | CA$1,468,000 | Quarter - 31 Mar 2026 | Open Canopy Growth Corp Share-based Payment Arrangement, Noncash Expense |
| 5 | EVOME MEDICAL TECHNOLOGIES INC. | CA$1,288,455 | Year - 31 Dec 2023 | Open EVOME MEDICAL TECHNOLOGIES INC. Share-based Payment Arrangement, Noncash Expense |
| 6 | NexMetals Mining Corp. (nexm) | CA$900,056 | Quarter - 31 Mar 2026 | Open NexMetals Mining Corp. Share-based Payment Arrangement, Noncash Expense |
Metric Details
- Metric
- Share-based Payment Arrangement, Noncash Expense (ShareBasedCompensation)
- Frequency coverage
-
annual and quarterly
Comparability: Compare annual with annual and quarterly with quarterly
- Taxonomy
- us-gaap
- Units tracked
- CAD
- History range
-
28 Feb 2021 - 31 Dec 2023
Freshness: From parsed SEC XBRL facts on this page
- Facts on this page
-
7
Source: SEC company facts API
- Metric definition
- Amount of noncash expense for share-based payment arrangement.
- SEC metric endpoint
- Open SEC company concept
Metric identity
Names, identifiers, and filing context for this profile.
1 identity field
Metric coverage
3 source fields
How to read it
1 detail
Source evidence
Original filing metadata and source links for verification.
1 source field
Chart Context
Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.
Share-based Payment Arrangement, Noncash Expense, Annual (CAD)
Share-based Payment Arrangement, Noncash Expense, YoY Annual Change (%)
Share-based Payment Arrangement, Noncash Expense, Quarterly (CAD)
Share-based Payment Arrangement, Noncash Expense, YoY Quarterly Change (%)
EVOME MEDICAL TECHNOLOGIES INC. Annual Share-based Payment Arrangement, Noncash Expense (CAD)
| Period | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|
| 2023 | CA$1,288,455 | 01 Jan 2023 | 31 Dec 2023 | 10-K | 16 Apr 2024 | 2023 | FY | ||
| 2021 | CA$1,196,361 | +CA$958,647 | +403% | 01 Mar 2021 | 28 Feb 2022 | 10-KT | 03 Apr 2023 | 2022 | FY |
| 2020 | CA$237,714 | 01 Mar 2020 | 28 Feb 2021 | 10-K | 31 May 2022 | 2022 | FY |
EVOME MEDICAL TECHNOLOGIES INC. Quarterly Share-based Payment Arrangement, Noncash Expense (CAD)
| Period | TTM Value | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 2023 | CA$345,524 | -CA$93,045 | -21% | 01 Jan 2023 | 31 Mar 2023 | 10-Q | 15 May 2023 | 2023 | Q1 | |
| Q2 2022 | CA$489,089 | +CA$470,002 | +2462% | 01 Mar 2022 | 31 May 2022 | 10-Q | 15 Jul 2022 | 2023 | Q1 | |
| Q1 2022 | CA$438,569 | 01 Jan 2022 | 31 Mar 2022 | 10-Q | 15 May 2023 | 2023 | Q1 | |||
| Q2 2021 | CA$19,087 | +CA$7,881 | +70% | 01 Mar 2021 | 31 May 2021 | 10-Q | 15 Jul 2022 | 2023 | Q1 |
* marks a reported value that did not pass the local value check.